2Del Rio C, Hemandez-Avila M.Lessons ~om previous influenza pandemics and from the Mexican response to the current influenza pandemic.Arch Med Res,2009,40(8):677-680. 被引量：1
3Eupropean centre for Disease Prevention and Control.European In- fluenza Surveillance Network(EISN)[EB/OL]. [2011-04-10] .http:// ecdc.europa.eu/erdactivities/surveillance/EISN/Pages/index.aspx. 被引量：1
4Baxter. Baxter Receives European Commission Approval for CELVAPAN H1N1 Pandemic Influenza Vaccine [EB/OL]. [2011-05-10] .http://www.baxter.com/pressroom/press_relea- ses/2009/10 07 0%celvapan.html. 被引量：1
5Partridge J, Kieny M P. Global production of seasonal and pan- demic (HIN1) influenza vaccines in 2009-2010 and comparison with previous estimates and global action plan targets[J].Vaccine, 2010.28(30):4709-4712. 被引量：1
6WHO.Safety of pandemic vaccines[EB/OL]. [2011-04-15].http:// www.who.int/csr/disease/swineflu/notes/briefmg_20091119/en/ index.html. 被引量：1
